These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3112295)

  • 1. [Study on the neuroendocrinological control of prolactin release in early puerperium].
    Kubota T; Kamada S; Tsuzuki H; Tei A; Saito M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1108-14. PubMed ID: 3112295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prolactin-releasing mechanism of the hypothalamo-pituitary axis in pregnancy.
    Kubota T; Yaoi Y; Nagae M; Kumasaka T; Saito M
    Fertil Steril; 1984 Nov; 42(5):724-9. PubMed ID: 6436068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of dopaminergic agents on the endocrine profile in labor and early puerperium].
    Kubota T; Nagae M; Kamata S; Oohara M; Saito M; Kumasaka T; Yaoi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):945-54. PubMed ID: 4020203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the hypothalamic dopaminergic activity in different stages of pregnancy and non-pregnancy].
    Kubota T
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jul; 36(7):1017-26. PubMed ID: 6431039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that opioid peptides and dopamine participate in the suckling-induced release of prolactin in the ewe.
    Knight PG; Howles CM; Cunningham FJ
    Neuroendocrinology; 1986; 44(1):29-35. PubMed ID: 3097561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are fasting-induced effects on thyrotropin and prolactin secretion mediated by dopamine?
    Röjdmark S
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1266-70. PubMed ID: 6404923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does bromocriptine block thyrotropin-releasing hormone-induced prolactin release during pregnancy?
    Ylikorkala O; Kivinen S; Rönnberg L; Viinikka L
    J Clin Endocrinol Metab; 1980 Mar; 50(3):600-2. PubMed ID: 6766949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cimetidine effect of dopaminergic modulation of prolactin release in healthy women.
    Röjdmark S; Andersson DE
    Metabolism; 1982 Oct; 31(10):1042-5. PubMed ID: 7132728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histaminergic regulation of prolactin secretion: dose-response relationship and possible involvement of the dopaminergic system.
    Knigge U; Thuesen B; Christiansen PM
    J Clin Endocrinol Metab; 1986 Mar; 62(3):491-6. PubMed ID: 3944233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery.
    Barbarino A; de Marinis L; Menini E; Anile C; Maira G
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):397-409. PubMed ID: 112818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine is unable to suppress TRH-stimulated beta-endorphin/beta-lipotropin and cortisol secretion in normal pregnant women after delivery.
    Lamberts SW; Angement R; van der Heijden A; Wladimiroff JW; Hackeng WH; de Jong FH
    Horm Res; 1987; 27(4):195-9. PubMed ID: 2963790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin secretion after bromocriptine in the hypophysial stalk-transfected gilt.
    Kraeling RR; Estienne MJ; Barb CR; Rampacek GB
    Life Sci; 1994; 54(22):1681-5. PubMed ID: 8177009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic evaluation of prolactin secretion by successive TRH and metoclopramide stimulations.
    Kauppila A; Heikkinen J; Viinikka L
    Acta Endocrinol (Copenh); 1986 Jan; 111(1):10-6. PubMed ID: 3080846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin release in man: influence of cimetidine, thyrotrophin-releasing hormone and acute hypercalcaemia.
    Röjdmark S
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):481-5. PubMed ID: 6405569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin release in pseudopregnant rats.
    Haisenleder DJ; Moy JA; Gala RR; Lawson DM
    Endocrinology; 1986 Nov; 119(5):1989-95. PubMed ID: 3095097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of pharmacodynamic tests in the hyperprolactinaemic syndrome.
    Ayalon D; Persitz E; Ravid R; Jedwab G; Avidan S; Cordova T; Harell A
    Clin Endocrinol (Oxf); 1979; 11(2):201-15. PubMed ID: 114343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H1 receptor participation in the control of prolactin secretion in postpartum.
    Messinis IE; Souvatzoglou A; Fais N; Lolis D
    J Endocrinol Invest; 1985 Apr; 8(2):143-6. PubMed ID: 3928731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro release of prolactin by thyrotropin-releasing hormone: influence of dopamine, thyroxine, and cycloheximide.
    Turpen C; Knigge KM
    Horm Res; 1979; 11(3):128-41. PubMed ID: 114468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased prolactin responsiveness to thyrotrophin-releasing hormone and metoclopramide in hyperthyroidism.
    Röjdmark S; Carlsson A
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):221-6. PubMed ID: 2998132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.